By Marisa Battistella, PharmD, Pharmacy Clinician Scientist, Nephrology Pharmacist - University Health Network, Associate Professor - University of Toronto. Presented on May 2, 2019 at the RPN Nephrology Education Afternoon 2019 - Montreal, … [Read more...] about DOAC Use in CKD – Is it safe?
Polypharmacy in HD Patients – Review of the Ontario and BC Databases
By Marisa Battistella, PharmD, Pharmacy Clinician Scientist and Assistant Professor, University Health Network and Leslie Dan Faculty of Pharmacy, University of Toronto and Judith Marin, PharmD, Clinical Pharmacy Specialist - Nephrology, St. Paul's … [Read more...] about Polypharmacy in HD Patients – Review of the Ontario and BC Databases
FISH Trial Journal Club
By Marisa Battistella, PharmD, Toronto General Hospital, University Health Network, Toronto, ON. Presented on April 25, 2013 at the Renal Pharmacists Network Nephrology Education Day - Montreal, QC. Download PDF Here … [Read more...] about FISH Trial Journal Club
Hepcidin and Iron Metabolism in CKD: What the Clinical Pharmacist Needs to Know!
By Marisa Battistella, PharmD, Pharmacy Clinician Scientist and Nephrology Pharmacist - University Health Network. Presented on March 23, 2012 at the Renal Pharmacists Network Nephrology Education Day Download PDF Here … [Read more...] about Hepcidin and Iron Metabolism in CKD: What the Clinical Pharmacist Needs to Know!
Management of HIT in the Hemodialysis Patient
By Marisa Battistella, PharmD. Presented on April 8, 2011 at the Renal Pharmacists Network Nephrology Education Day Download PDF Here … [Read more...] about Management of HIT in the Hemodialysis Patient
Nocturnal Hemodialysis: A new sexy dialysis treatment and implications for pharmacists
By Marisa Battistella, PharmD. Presented on November 15, 2009 at the Renal Pharmacists Network Nephrology Education Brunch Download PDF Here … [Read more...] about Nocturnal Hemodialysis: A new sexy dialysis treatment and implications for pharmacists
